Andreas Bauman
Basel, BS 4031, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Radiolabelled somatostatin receptor antagonist versus agonist for peptide receptor radionuclide therapy in patients with metastatic pheochromocytoma or paraganglioma: a retrospective pilot study.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 30, 2026
Increased progression free survival with radiolabelled somatostatin receptor antagonist versus standard peptide receptor radionuclide therapy in patients with somatostatin receptor positive tumours.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 18, 2025
First-in-human administration of [61Cu]Cu-NODAGA-LM3 and head-to-head comparison with [68Ga]Ga-DOTA-TOC PET/CT as part of the phase I/II COPPER PET in NET study.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 12, 2025
Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 05, 2023
Early response monitoring during [177Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 20, 2023
Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 19, 2023
Improved quality control of [177Lu]Lu-PSMA I&T.
Journal: EJNMMI radiopharmacy and chemistry
Published: February 17, 2023
On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversion.
Journal: Nuclear medicine and biology
Published: April 16, 2020
Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 25, 2017
Development of 68Ga- and 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 10, 2015
An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes.
Journal: Chemical communications (Cambridge, England)
Published: August 19, 2014
Expression of different neurokinin-1 receptor (NK1R) isoforms in glioblastoma multiforme: potential implications for targeted therapy.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: February 21, 2014
Last Updated: 09/26/2026